Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 16775
Country/Region: South Africa
Year: 2016
Main Partner: Aurum Institute
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $3,340,825 Additional Pipeline Funding: $3,086,296

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $457,951
Care: TB/HIV (HVTB) $951,896
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $500,000
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $1,430,978
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 8,808
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 2,096
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 245,844
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 68,816
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 254,653
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 70,912
HTS_TST Service Delivery Point (Facility): VCT 2017 217,994
HTS_TST Service Delivery Point (Facility): VCT 2017 62,426
HTS_TST Service Delivery Point (Facility): VMMC 2017 1,033
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 254,652
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 70,912
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 254,652
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 70,912
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,059
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 252
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 29,444
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 8,255
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 70,099
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 70,099
KP_PREV Total estimated number of key population in the catchment area 2017 128,677
KP_PREV_den By key population type: People in prisons and enclosed settings (Denominator: Total estimated number of key population in the catchment area) 2017 128,677
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 67
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 18
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2,000
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 615
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 3,236
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 855
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 2,065
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 633
TB_SCREENDX Screen Results: Screened Positive for TB 2017 8,181
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 2,756
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 278
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 97,278
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 19,895
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 100,035
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 20,173
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 146
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 33
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 4,320
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,185
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 4,543
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,182
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 5,641
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,470
TX_CURR Aggregated Age/Sex: 15+ Female 2017 158
TX_CURR Aggregated Age/Sex: 15+ Female 2017 623
TX_CURR Aggregated Age/Sex: 15+ Male 2017 20,332
TX_CURR Aggregated Age/Sex: 15+ Male 2017 5,567
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 20,955
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 5,725
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 5,725
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 20,955
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 5,725
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 20,955
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 157
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 19
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 4,650
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,187
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 4,795
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,206
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 4,807
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,206
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 18,597
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 5,057
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 16,738
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 4,547
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 505
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 128
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 16,214
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 4,419
TX_PVLS Numerator: Indication: Targeted 2017 558
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 560
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 143
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 18,027
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 4,914
TX_PVLS_den Denominator: Indication: Targeted 2017 620
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 339
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 127
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 12,161
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,585
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 12,106
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 3,713
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 12,904
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 3,987
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 363
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 135
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12,542
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,873
VMMC_CIRC By Age: 10-14 2017 738
VMMC_CIRC By Age: 15-19 2017 3,986
VMMC_CIRC By Age: 20-24 2017 3,695
VMMC_CIRC By Age: 25-29 2017 5,906
VMMC_CIRC By Age: 30-49 2017 296
VMMC_CIRC By Age: 50+ 2017 146
VMMC_CIRC By circumcision technique: Device-based VMMC 2017 3,805
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 10,958
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 14,766
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 14,767
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 8,565
Cross Cutting Budget Categories and Known Amounts Total: $2,093,421
Human Resources for Health $1,129,878
Motor Vehicles: Purchased $248,604
Gender: Gender Equality $50,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Gender: Gender Based Violence (GBV) $100,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Key Populations: MSM and TG $564,939
Training of health workers and community outreach workers